Your browser doesn't support javascript.
loading
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Takahashi, Hirokazu; Kessoku, Takaomi; Kawanaka, Miwa; Nonaka, Michihiro; Hyogo, Hideyuki; Fujii, Hideki; Nakajima, Tomoaki; Imajo, Kento; Tanaka, Kenichi; Kubotsu, Yoshihito; Isoda, Hiroshi; Oeda, Satoshi; Kurai, Osamu; Yoneda, Masato; Ono, Masafumi; Kitajima, Yoichiro; Tajiri, Ryo; Takamori, Ayako; Kawaguchi, Atsushi; Aishima, Shinichi; Kage, Masayoshi; Nakajima, Atsushi; Eguchi, Yuichiro; Anzai, Keizo.
Afiliação
  • Takahashi H; Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.
  • Kessoku T; Liver Center, Saga University Hospital, Faculty of Medicine, Saga University, Saga, Japan.
  • Kawanaka M; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Nonaka M; Department of General Internal Medicine Kawasaki Medical Center, Kawasaki Medical School, Okayama, Japan.
  • Hyogo H; Department of Gastroenterology and Hepatology, JA Hiroshima General Hospital, Hatsukaichi, Japan.
  • Fujii H; Department of Gastroenterology and Hepatology, JA Hiroshima General Hospital, Hatsukaichi, Japan.
  • Nakajima T; Department of Gastroenterology and Hepatology, Osaka City Juso Hospital, Osaka, Japan.
  • Imajo K; Department of Premier Preventive Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tanaka K; Department of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
  • Kubotsu Y; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Isoda H; Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.
  • Oeda S; Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.
  • Kurai O; Liver Center, Saga University Hospital, Faculty of Medicine, Saga University, Saga, Japan.
  • Yoneda M; Liver Center, Saga University Hospital, Faculty of Medicine, Saga University, Saga, Japan.
  • Ono M; Department of Gastroenterology and Hepatology, Osaka City Juso Hospital, Osaka, Japan.
  • Kitajima Y; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Tajiri R; Internal Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Takamori A; Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.
  • Kawaguchi A; Department of Clinical Gastroenterology, Eguchi Hospital, Ogi, Japan.
  • Aishima S; Clinical Research Center, Saga University Hospital, Saga, Japan.
  • Kage M; Clinical Research Center, Saga University Hospital, Saga, Japan.
  • Nakajima A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Eguchi Y; Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan.
  • Anzai K; Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
Hepatol Commun ; 6(1): 120-132, 2022 01.
Article em En | MEDLINE | ID: mdl-34558835

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article